Share

Bankruptcy & Commercial Litigation
Blockchain, Smart Contracts & Digital Currencies
Cannabis
Corporate
Crisis Management
Cybersecurity & Data Privacy
Delaware Corporate, LLC & Partnership Law
Design, Fashion & Luxury
E-Discovery & Records Management
Energy & Utilities
Environment & Energy
Financial Institutions
Government Affairs
Government Contracts & Global Trade
Healthcare
Immigration
Impact Investing
Insurance Recovery, Litigation & Counseling
Intellectual Property
Labor & Employment Law
Life Sciences
Litigation
Manufacturing
Products Liability, Mass Torts & Consumer Class Actions
Proptech
Public Finance 
Real Estate
Renewable Energy
Sports & Entertainment
Tax & Employee Benefits 
Technology Transactions
Transportation, Logistics & Supply Chain Management
Trusts, Estates & Private Clients 
Venture Capital & Emerging Growth Companies
Search By:

4.27.2019

Maneesh Gulati, and Matt Uretsky speak at the Corporate Structure, Intellectual Property & FDA Legal Considerations for Life Science Startups session at the Medicine Innovation & Entrepreneurship Conference in New York City. Maneesh discusses Intellectual Property Considerations for Startups, and Matt reviews Legal Issues for Life Science Startups.

Reader Interactions